Lol, yeah, don’t announce any new ideas like tha

Lol, yeah, don’t announce any new ideas like that until it get approved... leronlimab is the only drug in the Ccr5 inhibitor class without the serious side effects. I think the fda is just being very careful, wanting to double check with the 700mg safety data. They have 800+ patients that took it now, should ease the mind of the worrywart fda.